Tanaka Y - Search Results

1

Does Baseline Prostate Volume Affect the Short-Term Outcome of Tamsulosin?

Masumori N, Tsukamoto T, Horita H, Sunaoshi K, Tanaka Y, Takeyama K, Sato E, Miyao N. Masumori N, et al. Among authors: tanaka y. Low Urin Tract Symptoms. 2014 May;6(2):113-6. doi: 10.1111/luts.12032. Epub 2013 Sep 13. Low Urin Tract Symptoms. 2014. PMID: 26663551

2

Is the short-term outcome of transurethral resection of the prostate affected by preoperative degree of bladder outlet obstruction, status of detrusor contractility or detrusor overactivity?

Tanaka Y, Masumori N, Itoh N, Furuya S, Ogura H, Tsukamoto T. Tanaka Y, et al. Int J Urol. 2006 Nov;13(11):1398-404. doi: 10.1111/j.1442-2042.2006.01589.x. Int J Urol. 2006. PMID: 17083391

3

[Long-term results of lower urinary tract symptoms and urinary flow rate after transurethral resection of the prostate].

Tanaka Y, Masumori N, Tsukamoto T, Furuya S, Furuya R, Ogura H. Tanaka Y, et al. Hinyokika Kiyo. 2007 Jun;53(6):369-73. Hinyokika Kiyo. 2007. PMID: 17628933 Free article. Japanese.

4

Treatment strategy according to findings on pressure-flow study for women with decreased urinary flow rate.

Tanaka Y, Masumori N, Tsukamoto T, Furuya S, Furuya R, Ogura H. Tanaka Y, et al. Adv Urol. 2009;2009:782985. doi: 10.1155/2009/782985. Epub 2009 Oct 13. Adv Urol. 2009. PMID: 19841751 Free PMC article.

5

Urodynamic effects of solifenacin in untreated female patients with symptomatic overactive bladder.

Tanaka Y, Masumori N, Tsukamoto T. Tanaka Y, et al. Int J Urol. 2010 Sep;17(9):796-800. doi: 10.1111/j.1442-2042.2010.02602.x. Epub 2010 Jul 23. Int J Urol. 2010. PMID: 20649825

6

α1-blocker tamsulosin as initial treatment for patients with benign prostatic hyperplasia: 5-year outcome analysis of a prospective multicenter study.

Masumori N, Tsukamoto T, Horita H, Sunaoshi K, Tanaka Y, Takeyama K, Sato E, Miyao N. Masumori N, et al. Among authors: tanaka y. Int J Urol. 2013 Apr;20(4):421-8. doi: 10.1111/j.1442-2042.2012.03165.x. Epub 2012 Sep 19. Int J Urol. 2013. PMID: 22989348 Clinical Trial.

7

A randomized controlled study of the efficacy of tamsulosin monotherapy and its combination with mirabegron for overactive bladder induced by benign prostatic obstruction.

Ichihara K, Masumori N, Fukuta F, Tsukamoto T, Iwasawa A, Tanaka Y. Ichihara K, et al. Among authors: tanaka y. J Urol. 2015 Mar;193(3):921-6. doi: 10.1016/j.juro.2014.09.091. Epub 2014 Sep 22. J Urol. 2015. PMID: 25254938 Clinical Trial.

8

The Persistence of Silodosin Monotherapy and the Reasons for Withdrawal from Treatment of Previously Untreated Japanese Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia.

Tanaka Y, Tanuma Y, Masumori N. Tanaka Y, et al. Adv Urol. 2017;2017:4842025. doi: 10.1155/2017/4842025. Epub 2017 Jun 13. Adv Urol. 2017. PMID: 28694823 Free PMC article.

9

Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia.

Tanaka Y, Masumori N, Itoh N, Sato Y, Takahashi A, Ogura H, Furuya S, Tsukamoto T. Tanaka Y, et al. J Urol. 2002 Jun;167(6):2492-5. J Urol. 2002. PMID: 11992065

10

Lower urinary tract symptoms of men seeking medical care--comparison of symptoms found in the clinical setting and in a community study.

Masumori N, Tanaka Y, Takahashi A, Itoh N, Ogura H, Furuya S, Tsukamoto T. Masumori N, et al. Among authors: tanaka y. Urology. 2003 Aug;62(2):266-72. doi: 10.1016/s0090-4295(03)00252-8. Urology. 2003. PMID: 12893333

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,381 results

Search Page

Filters